Hepatocellular carcinoma

Assess cancer risk and identify opportunities for increased surveillance

Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer in the world. While HCC can be effectively treated in its early stages, most patients are not diagnosed until they are symptomatic and at higher grades and stages, when the disease is less responsive to therapies. Laboratory testing and imaging can identify at-risk patients needing increased surveillance to help aid in early diagnosis.

Hepatocellular carcinoma Test menu

Hepatocellular carcinoma

Key testing



  1. Bertine G2, Ardiri AM, Calvango GS, et. al. Prognostic and diagnostic value of des-gamma-carboxy prothrombin in liver cancer. Drug News Perspect. 2010 Oct; 23(8):498-508.
  2. Data collected for TAS Wako i30 Analyzer and Test systems US FDA (510)k submission

Fill out the form below and one of our specialists will be in touch.